Hepatitis: Screening and Testing Methods

 

<p justify;"="" style="text-align: justify;">The disclosure of hepatitis infection (HV) has prompted the advancement of serological tests for the discovery of counteracting agent to this newfound infection. Gatherings at more serious danger of obtaining HV contamination incorporate intravenous medication clients, haemodialysis patients, haemophiliacs and blood transfusion beneficiaries. The screening of blood givers for hostile to HV has incredibly diminished the rate of post-transfusion hepatitis. One of the real issues with HV disease is the advancement of endless hepatitis in 50 to 60% of cases, which could prompt cirrhosis and hepatocellular carcinoma.

 

  • Serological assays for detection of HV infection
  • Molecular assays for the detection of HV infection
  • Quantitation of HV RNA
  • Genotyping of HV isolates

Related Conference of Hepatitis: Screening and Testing Methods

December 03-04, 2020

11th International Conference on Liver Diseases & Hepatology

Singapore City, Singapore
December 07-08, 2020

International Congress on Gastroenterology and Liver Transplant

Auckland, Newzealand
January 18-19, 2021

4th International Conference on Chemistry Education and Research

Singapore City, Singapore
March 30-31, 2021

7th International Conference on Hepatology

Osaka, Japan
April 12-13, 2021

16th Euro-Global Gastroenterology Conference

London, UK
May 07-08, 2021

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
July 13-14, 2021

International Conference on Hepatitis & Liver diseases

Shanghai, Australia
July 20-21, 2021

20th World Gastroenterologists Summit

Osaka, Japan
September 27-28, 2021

8th Global Conference on Mass Spectrometry

Tokyo, Japan
September 28-29, 2021

2 nd World Congress on Oil and Gas Engineering

Auckland, Newzealand

Hepatitis: Screening and Testing Methods Conference Speakers

Recommended Sessions

Related Journals

Are you interested in